Shariah compliance overview
HalalKiniksa Pharmaceuticals International, plc (KNSA) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
Kiniksa Pharmaceuticals International, plc (KNSA) operates in the Healthcare sector, in the Medical - Pharmaceuticals industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 3.37% (limit 5%), interest-bearing debt is 0.13% (limit 30%) and interest-bearing securities and assets are 18.71% (limit 30%).
If you hold KNSA, give 2.53% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 3.37%Limit 5%Pass
- Interest-bearing debt
- 0.13%Limit 30%Pass
- Interest-bearing securities and assets
- 18.71%Limit 30%Pass
- Dividend purification
- 2.53%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Kiniksa Pharmaceuticals International, plc (KNSA). Current Akinda screening label: Halal.
